Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections [3]

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1693-1695

  Carter, Melinda K ^a   Ebers, Vernessa A ^a   Younes, Bachir K ^a   Lacy, Melinda K ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFALEXIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; NITROFURANTOIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC THERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; COMMUNITY CARE; DRUG EFFICACY; DRUG PENETRATION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; RETROSPECTIVE STUDIES; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33748300737     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H084     Document Type: Letter

References (4)

1. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005;25:74-85.
2. Ruhe JJ, Monson T, Bradsher RW, et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005;40:1429-34.
3. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373-406.
4. Treatment of community-associated MRSA infections. Med Lett Drugs Ther 2006;48:13-4.